Mersana Therapeutics Inc Capital Reinvestment Ratio
Mersana Therapeutics Inc capital reinvestment ratio. Mersana Therapeutics Inc (MRSN) has a Capital Reinvestment Ratio of 0.01x as of September 2022, meaning it reinvests 0% of its operating cash flow ($54.60 Million) in capital expenditures ($426.00K). Check MRSN capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Mersana Therapeutics Inc (2016–2016)
Capital reinvestment ratio of Mersana Therapeutics Inc from 2016 to 2016. This chart tracks Mersana Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. Also explore Mersana Therapeutics Inc (MRSN) equity growth momentum to track the company's year-over-year net asset growth rate.
Mersana Therapeutics Inc Capital Reinvestment Ratio by Year (2016–2016)
Mersana Therapeutics Inc capital reinvestment ratio by year from 2016 to 2016. For the full cash flow conversion analysis, see MRSN cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2016 | 0.03x | $31.59 Million | $1.08 Million | — |